Category: Media Coverage

Read the latest news from Beghou Consulting, as well as our experts’ views on trends and challenges in the life sciences industry.

Dan Schulman addresses key considerations in orphan drug commercialization

Orphan drugs are different than mass-market therapies — and so is their commercial strategy. Orphan drug manufacturers should engage patients throughout research, development and commercialization — and hire specialized sales forces market the therapy to the most relevant physicians. Associate Partner Dan Schulman describes in Med Ad News the steps orphan drug manufacturers can take to ensure their life-saving treatments reach patients as quickly as possible.
Read More »

Esin Izat and Rob Lien on navigating the patient journey to inform commercial operations

An orphan drug manufacturer should follow the patient journey to account for various scenarios in the product’s forecast — from delays in therapy starts to patient compliance and retention. Associate Partner Rob Lien and Manager Esin Izat describe in Pharmaceutical Commerce how detailed analysis and marketing research can help life sciences companies overcome these challenges and contribute to commercial success.
Read More »

Dan Wetherill and Janardhan Vellore on how to "get ahead of scripts"

A life sciences company needs to rely on more than historical prescription volume to ensure product success in today’s hypercompetitive marketplace. Partner Dan Wetherill and Vice President Janardhan Vellore describe in Pharmaceutical Executive how life sciences companies can proactively increase the breadth and depth of prescriptions to propel brand performance.
Read More »

ARMADA™ NAMED ONE OF PM360’S MOST INNOVATIVE PRODUCTS OF 2019

Beghou Consulting’s cloud-based data analytics platform, ARMADA™, was named one of the most innovative products of 2019. With more data available than ever before, ARMADA enables life sciences companies to manage and analyze vast amounts of data quickly and efficiently – and uncover insights five times faster than traditional processing methods. Read more in PM360 magazine.
Read More »

Beth Beghou and Patrick Lezark on how emerging pharma can use advanced analytics to improve commercial operations

The 2019 Emerging Pharma Pulse Report found that nearly 60% of emerging pharma companies only use advanced analytics “somewhat” or “to a limited extent” to generate commercial insights. Managing Director Beth Beghou and Partner Patrick Lezark share with Pharmaceutical Executive how emerging pharma companies can implement an advanced analytics to improve all facets of commercial operations.
Read More »

Jon Hesby, Melissa McDevitt and Esin Izat on how to optimize operations after a product's first birthday

A product’s first birthday offers an ideal time for the commercial team to analyze sales and optimize operations. A year’s worth of sales data and proper computing power enables life sciences companies to examine sales and marketing tactics to see what’s working and what’s not – and then take appropriate action. Jon Hesby, Melissa McDevitt and Esin Izat describe in Pharmaceutical Executive how to enhance sales force effectiveness as part of the post-launch commercialization strategy.
Read More »